Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer

Qiong Yang,1–3,* Yuanyuan Huang,4–6,* Zhimin Jiang,1–3 Huizhong Wang,1–3 Weiyu Li,1–3 Bei Zhang,4–6 Derong Xie1–3 1Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; 2Guangdong Provin...

Full description

Bibliographic Details
Main Authors:	Yang Q, Huang YY, Jiang ZM, Wang HZ, Li WY, Zhang B, Xie DR
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-05-01
Series:	OncoTargets and Therapy
Subjects:	oxaliplatin later-line therapy metastatic colorectal cancer
Online Access:	https://www.dovepress.com/rechallenge-of-oxaliplatin-containing-regimens-in-the-third--or-later--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/rechallenge-of-oxaliplatin-containing-regimens-in-the-third--or-later--peer-reviewed-article-OTT

Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer

Internet

Similar Items